Mechanism of breast cancer preventive action of pomegranate: Disruption of estrogen receptor and Wnt/β-catenin signaling pathways

Molecules

Volumn 20, Issue 12, 2015, Pages 22315-22328

  Mandal, Animesh ^a   Bishayee, Anupam ^b   Lam, Christopher W K ^c  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b Larkin Health Science Institute   (United States)

^c NONE

Author keywords

Cyclin D1; DMBA; Estrogen receptors; Mammary tumorigenesis; Pomegranate (Punica granatum L.); catenin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ANTINEOPLASTIC AGENT; BETA CATENIN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; WNT PROTEIN;

ANIMAL; BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION; CHEMISTRY; CHEMOPROPHYLAXIS; DOWN REGULATION; DRUG EFFECTS; FEMALE; LYTHRACEAE; METABOLISM; PROCEDURES; RAT; SPRAGUE DAWLEY RAT; WNT SIGNALING PATHWAY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; ANTICARCINOGENIC AGENTS; BETA CATENIN; BREAST NEOPLASMS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHEMOPREVENTION; DOWN-REGULATION; ESTROGEN RECEPTOR ALPHA; FEMALE; PUNICACEAE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84954341706     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201219853     Document Type: Article

References (88)

1. Ferlay, J.; Soerjomataram, I.; Dikshit, R.; Eser, S.; Mathers, C.; Rebelo, M.; Parkin, D.M.; Forman, D.; Bray, F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015, 136, E359-E386.
2. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2015. CA Cancer J. Clin. 2015, 65, 5-29.
3. Ottini, L. Male breast cancer: A rare disease that might uncover underlying pathways of breast cancer. Nat. Rev. Cancer 2014, 14, 643.
4. Lillie, S.E.; Brewer, N.T.; O'Neill, S.C.; Morrill, E.F.; Dees, E.C.; Carey, L.A.; Rimer, B.K. Retention and use of breast cancer recurrence risk information from genomic tests: The role of health literacy. Cancer Epidemiol. Biomark. Prev. 2007, 16, 249-255.
5. Campeau, P.M.; Foulkes, W.D.; Tischkowitz, M.D. Hereditary breast cancer: New genetic developments, new therapeutic avenues. Hum. Genet. 2008, 124, 31-42.
6. Bozovic-Spasojevic, I.; Azambuja, E.; McCaskill-Stevens, W.; Dinh, P.; Cardoso, F. Chemoprevention for breast cancer. Cancer Treat. Rev. 2012, 38, 329-339.
7. Files, J.A.; Stan, D.L.; Allen, S.V.; Pruthi, S. Chemoprevention of breast cancer. Women's Health 2012, 8, 635-646.
8. Fagundes, C.P.; Lindgren, M.E.; Shapiro, C.L.; Kiecolt-Glaser, J.K. Child maltreatment and breast cancer survivors: Social support makes a difference for quality of life, fatigue and cancer stress. Eur. J. Cancer 2012, 48, 728-736.
9. Narod, S.A. Hormone replacement therapy and the risk of breast cancer. Nat. Rev. Clin. Oncol. 2011, 8, 669-676.
10. Park, S.Y.; Kolonel, L.N.; Lim, U.; White, K.K.; Henderson, B.E.; Wilkens, L.R. Alcohol consumption and breast cancer risk among women from five ethnic groups with light to moderate intakes: The Multiethnic Cohort Study. Int. J. Cancer 2014, 134, 1504-1510.
11. Crujeiras, A.B.; Díaz-Lagares, A.; Carreira, M.C.; Amil, M.; Casanueva, F.F. Oxidative stress associated to dysfunctional adipose tissue: A potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic. Res. 2013, 47, 243-256.
12. Pierobon, M.; Frankenfeld, C.L. Obesity as a risk factor for triple-negative breast cancers: A systematic review and meta-analysis. Breast Cancer Res. Treat. 2013, 137, 307-314.
13. Jia, Y.; Lu, Y.; Wu, K.; Lin, Q.; Shen, W.; Zhu, M.; Huang, S.; Chen, J. Does night work increase the risk of breast cancer? A systematic review and meta-analysis of epidemiological studies. Cancer Epidemiol. 2013, 37, 197-206.
14. Cazzaniga, M.; Bonanni, B. Breast cancer chemoprevention: Old and new approaches. J. Biomed. Biotechnol. 2012, 2012, 985620.
15. Eccles, S.A.; Aboagye, E.O.; Ali, S.; Anderson, A.S.; Armes, J.; Berditchevski, F.; Blaydes, J.P.; Brennan, K.; Brown, N.J.; Bryant, H.E.; et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res. 2013, 15, R92.
16. Song, J.K.; Bae, J.M. Citrus fruit intake and breast cancer risk: A quantitative systemic review. J. Breast Cancer 2013, 16, 72-76.
17. Ogunleye, A.A.; Xue, F.; Michels, K.B. Green tea consumption and breast cancer risk or recurrence: A meta-analysis. Breast Cancer Res. Treat. 2010, 119, 477-484.
18. Mourouti, N.; Panagiotakos, D.B. Soy food consumption and breast cancer. Maturitas 2013, 76, 118-122.
19. Aune, D.; Chan, D.S.; Vieira, A.R.; Navarro Rosenblatt, D.A.; Vieira, R.; Greenwood, D.C.; Norat, T. Dietary compared with blood concentrations of carotenoids and breast cancer risk: A systematic review and meta-analysis of prospective studies. Am. J. Clin. Nutr. 2012, 96, 356-373.
20. Thomson, C.A.; Flatt, S.W.; Rock, C.L.; Ritenbaugh, C.; Newman, V.; Pierce, J.P. Increased fruit, vegetable and fiber intake and lower fat intake reported among women previously treated for invasive breast cancer. J. Am. Diet Assoc. 2002, 102, 801-808.
21. Rock, C.L.; Demark-Wahnefried, W. Nutrition and survival after the diagnosis of breast cancer: A review of the evidence. J. Clin. Oncol. 2002, 20, 3302-3316.
22. Khan, S.I.; Zhao, J.; Khan, I.A.; Walker, L.A.; Dasmahapatra, A.K. Potential utility of natural products as regulators of breast cancer-associated aromatase promoters. Reprod. Biol. Endocrinol. 2011, 9, 91.
23. Reuben, S.C.; Gopalan, A.; Petit, D.M.; Bishayee, A. Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer. Mol. Nutr. Food Res. 2012, 56, 14-29.
24. Sinha, D.; Biswas, J.; Sung, B.; Aggarwal, B.B.; Bishayee, A. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer. Curr. Drug Targets 2012, 13, 1799-1819.
25. Aiyer, H.S.; Warri, A.M.; Woode, D.R.; Hilakivi-Clarke, L.; Clarke, R. Influence of berry polyphenols on receptor signaling and cell-death pathways: Implications for breast cancer prevention. J. Agric. Food Chem. 2012, 60, 5693-5708.
26. Vadodkar, A.S.; Suman, S.; Lakshmanaswamy, R.; Damodaran, C. Chemoprevention of breast cancer by dietary compounds. Anticancer Agents Med. Chem. 2012, 12, 1185-1202.
27. Takemura, H.; Sakakibara, H.; Yamazaki, S.; Shimoi, K. Breast cancer and flavonoids - A role in prevention. Curr. Pharm. Des. 2013, 19, 6125-6132.
28. Yiannakopoulou, E.C. Effect of green tea catechins on breast carcinogenesis: A systematic review of in vitro and in vivo experimental studies. Eur. J. Cancer Prev. 2014, 23, 84-89.
29. Parikh, N.R.; Mandal, A.; Bhatia, D.; Siveen, K.S.; Sethi, G.; Bishayee, A. Oleanane triterpenoids in the prevention and therapy of breast cancer: Current evidence and future perspectives. Phytochem. Rev. 2014, 13, 793-810.
30. Kado, K.; Forsyth, A.; Patel, P.R.; Schwartz, J.A. Dietary supplements and natural products in breast cancer trials. Front. Biosci. 2012, 4, 546-567.
31. Siddiqui, J.A.; Singh, A.; Chagtoo, M.; Singh, N.; Godbole, M.M.; Chakravarti, B. Phytochemicals for breast cancer therapy: Current status and future implications. Curr. Cancer Drug Targets 2015, 15, 116-135.
32. Lansky, E.P.; Newman, R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J. Ethnopharmacol. 2007, 109, 177-206.
33. Jurenka, J.S. Therapeutic applications of pomegranate (Punica granatum L.): A review. Altern. Med. Rev. 2008, 13, 128-144.
34. Johanningsmeier, S.D.; Harris, G.K. Pomegranate as a functional food and nutraceutical source. Annu. Rev. Food Sci. Technol. 2011, 2, 181-201.
35. Faria, A.; Calhau, C. The bioactivity of pomegranate: Impact on health and disease. Crit. Rev. Food Sci. Nutr. 2011, 51, 626-634.
36. Syed, D.N.; Chamcheu, J.C.; Adhami, V.M.; Mukhtar, H. Pomegranate extracts and cancer prevention: molecular and cellular activities. Anticancer Agents Med. Chem. 2013, 13, 1149-1161.
37. Turrini, E.; Ferruzzi, L.; Fimognari, C. Potential effects of pomegranate polyphenols in cancer prevention and therapy. Oxid. Med Cell. Longev. 2015, 2015, 938475.
38. Kim, N.D.; Mehta, R.; Yu, W.; Neeman, I.; Livney, T.; Amichay, A.; Poirier, D.; Nicholls, P.; Kirby, A.; Jiang, W.; et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res. Treat. 2002, 71, 203-217.
39. Toi, M.; Bando, H.; Ramachandran, C.; Melnick, S.J.; Imai, A.; Fife, R.S.; Carr, R.E.; Oikawa, T.; Lansky, E.P. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 2003, 6, 121-128.
40. Khan, G.N.; Gorin, M.A.; Rosenthal, D.; Pan, Q.; Bao, L.W.; Wu, Z.F.; Newman, R.A.; Pawlus, A.D.; Yang, P.; Lansky, E.P.; et al. Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr. Cancer Ther. 2009, 8, 242-253.
41. Adams, L.S.; Zhang, Y.; Seeram, N.P.; Heber, D.; Chen, S. Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev. Res. 2010, 3, 108-113.
42. Dai, Z.; Nair, V.; Khan, M.; Ciolino, H.P. Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro. Oncol. Rep. 2010, 24, 1087-1091.
43. Dikmen, M.; Ozturk, N.; Ozturk, Y. The antioxidant potency of Punica granatum L. fruit peel reduces cell proliferation and induces apoptosis on breast cancer. J. Med. Food 2011, 14, 1638-1646.
44. Joseph, M.M.; Aravind, S.R.; Varghese, S.; Mini, S.; Sreelekha, T.T. Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum. Mol. Med. Rep. 2012, 5, 489-496.
45. Banerjee, N.; Talcott, S.; Safe, S.; Mertens-Talcott, S.U. Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: Potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res. Treat. 2012, 136, 21-34.
46. Rocha, A.; Wang, L.; Penichet, M.; Martins-Green, M. Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Res. Treat. 2012, 136, 647-658.
47. Sreeja, S.; Santhosh Kumar, T.R.; Lakshmi, B.S.; Sreeja, S. Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation. J. Nutr. Biochem. 2012, 23, 725-732.
48. Shirode, A.B.; Kovvuru, P.; Chittur, S.V.; Henning, S.M.; Heber, D.; Reliene, R. Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol. Carcinog. 2014, 53, 458-470.
49. Mehta, R.; Lansk, E.P. Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur. J. Cancer Prev. 2004, 13, 345-348.
50. Bishayee, A.; Mandal, A.; Bhattacharyya, P.; Bhatia, D. Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutr. Cancer 2015.
51. Matthews, J.; Gustafsson, J.A. Estrogen signaling: A subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 3, 281-292.
52. Williams, G.P. The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. Eur. J. Cancer Prev. 2010, 19, 256-271.
53. Russo, J.; Russo, I.H. Experimentally induced mammary tumors in rats. Breast Cancer Res. Treat. 1996, 39, 7-20.
54. Kilańczyk, E.; Gwoździński, K.; Wilczek, E.; Filipek, A. Up-regulation of CacyBP/SIP during rat breast cancer development. Breast Cancer 2014, 21, 350-357.
55. Yager, J.D.; Davidson, N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006, 354, 270-282.
56. Althuis, M.D.; Fergenbaum, J.H.; Garcia-Closas, M.; Brinton, L.A.; Madigan, M.P.; Sherman, M.E. Etiology of hormone receptor-defined breast cancer: A systematic review of the literature. Cancer Epidemiol. Biomark. Prev. 2004, 13, 1558-1568.
57. Korach, K.S.; Couse, J.F.; Curtis, S.W.; Washburn, T.F.; Lindzey, J.; Kimbro, K.S.; Eddy, E.M.; Migliaccio, S.; Snedeker, S.M.; Lubahn, D.B.; et al. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes. Recent Prog. Horm. Res. 1996, 51, 159-186.
58. Saji, S.; Jensen, E.V.; Nilsson, S.; Rylander, T.; Warner, M.; Gustafsson, J.A. Estrogen receptors alpha and beta in the rodent mammary gland. Proc. Natl. Acad. Sci. USA 2000, 97, 337-342.
59. Leygue, E.; Dotzlaw, H.; Watson, P.H.; Murphy, L.C. Altered estrogen receptor α and β messenger RNA expression during human breast tumorigenesis. Cancer Res. 1998, 58, 3197-3201.
60. Lazennce, G.; Bresson, D.; Lucas, A.; Chauveau, C.; Vignon, F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001, 142, 4120-4130.
61. Jordan, V.C. Chemoprevention of breast cancer with selective oestrogen-receptor modulators. Nat. Rev. Cancer 2007, 7, 46-53.
62. Cuzick, J.; DeCensi, A.; Arun, B.; Brown, P.H.; Castiglione, M.; Dunn, B.; Forbes, J.F.; Glaus, A.; Howell, A.; von Minckwitz, G.; et al. Preventive therapy for breast cancer: A consensus statement. Lancet Oncol. 2011, 12, 496-503.
63. Roger, P.; Sahla, M.E.; Mäkelä, S.; Gustafsson, J.A.; Baldet, P.; Rochefort, H. Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res. 2001, 61, 2537-2541.
64. Brennan, K.R.; Brown, A.M.C. Wnt proteins in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 2004, 9, 119-131.
65. Incassati, A.; Chandramouli, A.; Eelkema, R.; Cowin, P. Key signaling nodes in mammary gland development and cancer: β-catenin. Breast Cancer Res. 2010, 12, 213.
66. Clevers, H. Wnt/β-catenin signaling in development and disease. Cell 2006, 127, 469-480.
67. Ozaki, S.; Ikeda, S.; Ishizaki, Y.; Kurihara, T.; Tokumoto, N.; Iseki, M.; Arihiro, K.; Kataoka, T.; Okajima, M.; Asahara, T. Alterations and correlations of the components in the Wnt signaling pathway and its target genes in breast cancer. Oncol. Rep. 2005, 14, 1437-1443.
68. Khramtsov, A.I.; Khramtsova, G.F.; Tretiakova, M.; Huo, D.; Olopade, O.I.; Goss, K.H. Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am. J. Pathol. 2010, 176, 2911-2920.
69. López-Knowles, E.; Zardawi, S.J.; McNeil, C.M.; Millar, E.K.; Crea, P.; Musgrove, E.A.; Sutherland, R.L.; O'Toole, S.A. Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol. Biomarkers Prev. 2010, 19, 301-309.
70. Prasad, C.P.; Gupta, S.D.; Rath, G.; Ralhan, R. Wnt signaling pathway in invasive ductal carcinoma of the breast: Relationship between beta-catenin, dishevelled and cyclin D1 expression. Oncology 2007, 73, 112-117.
71. Karayiannakis, A.J.; Nakopoulou, L.; Gakiopoulou, H.; Keramopoulos, A.; Davaris, P.S.; Pignatelli, M. Expression patterns of beta-catenin in in situ and invasive breast cancer. Eur. J. Surg. Oncol. 2001, 27, 31-36.
72. Currier, N.; Solomon, S.E.; Demicco, E.G.; Chang, D.L.; Farago, M.; Ying, H.; Dominguez, I.; Sonenshein, G.E.; Cardiff, R.D.; Xiao, Z.X.; et al. Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors. Toxicol. Pathol. 2005, 33, 726-737.
73. Li, H.; Pamukcu, R.; Thompson, W.J. β-Catenin signaling: Therapeutic strategies in oncology. Cancer Biol. Ther. 2002, 1, 621-625.
74. Bhatia, D.; Thoppil, R.J.; Mandal, A.; Samtani, K.A.; Darvesh, A.S.; Bishayee, A. Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/β-Catenin Signaling Pathway. Evid. Based Complement. Altern. Med. 2013, 2013, 371813.
75. Sharma, M.; Li, L.; Celver, J.; Killian, C.; Kovoor, A.; Seeram, N.P. Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J. Agric. Food Chem. 2010, 58, 3965-3969.
76. Sadik, N.A.; Shaker, O.G. Inhibitory effect of a standardized pomegranate fruit extract on Wnt signalling in 1,2-dimethylhydrazine induced rat colon carcinogenesis. Dig. Dis. Sci. 2013, 58, 2507-2517.
77. Neuman, E.; Ladha, M.H.; Lin, N.; Upton, T.M.; Miller, S.J.; DiRenzo, J.; Pestell, R.G.; Hinds, P.W.; Dowdy, S.F.; Brown, M.; et al. Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol. Cell. Biol. 1997, 17, 5338-5347.
78. Caldon, C.E.; Sutherland, R.L.; Musgrove, E. Cell cycle proteins in epithelial cell differentiation: Implications for breast cancer. Cell Cycle 2010, 9, 1918-1928.
79. Roy, P.G.; Thompson, A.M. Cyclin D1 and breast cancer. Breast 2006, 15, 718-727.
80. Kuramoto, T.; Morimura, K.; Yamashita, S.; Okochi, E.; Watanabe, N.; Ohta, T.; Ohki, M.; Fukushima, S.; Sugimura, T.; Ushijima, T. Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res. 2002, 62, 3592-3597.
81. Shan, L.; He, M.; Yu, M.; Qiu, C.; Lee, N.H.; Liu, E.T.; Snyderwine, E.G. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 2002, 23, 1561-1568.
82. Papaconstantinou, A.D.; Shanmugam, I.; Shan, L.; Schroeder, I.S.; Qiu, C.; Yu, M.; Snyderwine, E.G. Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene. Int. J. Cancer 2006, 118, 17-24.
83. Tetsu, O.; McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398, 422-426.
84. Seeram, N.P.; Adams, L.S.; Henning, S.M.; Niu, Y.; Zhang, Y.; Nair, M.G.; Heber, D. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J. Nutr. Biochem. 2005, 16, 360-367.
85. Lansky, E.P.; Jiang, W.; Mo, H.; Bravo, L.; Froom, P.; Yu, W.; Harris, N.M.; Neeman, I.; Campbell, M.J. Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Investig. New Drugs 2005, 23, 11-20.
86. De Kok, T.M.; van Breda, S.G.; Manson, M.M. Mechanisms of combined action of different chemopreventive dietary compounds: A review. Eur. J. Nutr. 2008, 47, 51-59.
87. Bode, A.M.; Dong, Z. Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail. Cancer Prev. Res. 2009, 2, 514-517.
88. Bishayee, A.; Bhatia, D.; Thoppil, R.J.; Darvesh, A.S.; Nevo, E.; Lansky, E.P. Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 2011, 32, 888-896.